Immunotherapy may play role in treating nonmetastatic gastroesophageal cancer
EU plans to scrap Valneva’s COVID vaccine deal
16 May 2022Considering an IUD but worried about pain during insertion? Here’s what to expect
16 May 2022Immunotherapy may play role in treating nonmetastatic gastroesophageal cancer
Immunotherapy has transformed treatment for patients with stage 4 metastatic esophageal and gastric cancers. In patients with these malignancies, immunotherapy has been shown to prolong survival when patients’ tumors exhibit a high expression of an immune-related protein called PD-L1.
